Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
A1 | 1 | 39 | F | Brain | Diffuse astrocytoma | 2 | * | * | Malignant | * |
A2 | 2 | 36 | M | Brain | Anaplastic oligoastrocytoma | 3 | * | * | Malignant | * |
A3 | 3 | 45 | M | Brain | Glioblastoma | 4 | * | * | Malignant | * |
A4 | 4 | 53 | M | Adrenal gland | Cortical adenoma | * | * | * | Malignant | * |
A5 | 5 | 48 | F | Adrenal gland | Cortical adenocarcinoma | 2 | T2N0M0 | II | Malignant | 14*9*4 |
A6 | 6 | 45 | M | Adrenal gland | Cortical adenocarcinoma with necrosis | 2--3 | T3N0M0 | III | Malignant | * |
A7 | 7 | 58 | F | Ovary | High-grade serous carcinoma | * | T3cN0M0 | IIIC | Malignant | * |
A8 | 8 | 37 | F | Ovary | High-grade serous carcinoma | * | T1N0M0 | I | Malignant | 6.5*4.5*3 |
A9 | 9 | 67 | F | Ovary | High-grade serous carcinoma | * | T1N0M0 | I | Malignant | 13*12*6 |
B1 | 10 | 58 | F | Pancreas | Adenocarcinoma | 1 | T3N1M0 | IIB | Malignant | * |
B2 | 11 | 62 | M | Pancreas | Duct adenocarcinoma | 2 | T3N1M0 | IIB | Malignant | * |
B3 | 12 | 37 | F | Pancreas | Neuroendocrine carcinoma | * | T2N0M0 | IB | Malignant | * |
B4 | 13 | 1 | M | Testis | Embryonic rhabdomyosarcoma | * | T1bN0M0 | IIA | Malignant | * |
B5 | 14 | 55 | M | Testis | Embryonal carcinoma | * | T1N0M0 | IA | Malignant | * |
B6 | 15 | 50 | M | Testis | Seminoma with necrosis | * | T1N0M0 | IA | Malignant | * |
B7 | 16 | 50 | M | Thyroid gland | Medullary carcinoma | * | T3N0M0 | I | Malignant | * |
B8 | 17 | 20 | F | Thyroid gland | Papillary carcinoma | * | T2N0M0 | I | Malignant | * |
B9 | 18 | 45 | M | Thyroid gland | Follicular carcinoma | * | T2N0M0 | I | Malignant | 5.0 |
C1 | 19 | 53 | F | Breast | Invasive carcinoma of no special type (sparse) | 2 | T2N0M0 | IIA | Malignant | * |
C2 | 20 | 49 | F | Breast | Invasive lobular carcinoma | * | T4N0M0 | IIIB | Malignant | * |
C3 | 21 | 44 | F | Breast | Apocrine carcinoma | * | T3N0M0 | IIB | Malignant | * |
C4 | 22 | 61 | F | Spleen | Diffuse B cell lymphoma | * | * | * | Malignant | * |
C5 | 23 | 47 | M | Spleen | Diffuse B cell lymphoma | * | * | * | Malignant | * |
C6 | 24 | 35 | M | Spleen | Angiosarcoma | * | * | * | Malignant | 5.0 |
C7 | 25 | 35 | M | Thymus gland | Type B3 thymoma | * | T1N0M0 | I | Malignant | 11*7*3 |
C8 | 26 | 48 | M | Thymus gland | Thymic cancer | * | * | * | Malignant | 8*6*6 |
C9 | 27 | 56 | F | Thymus gland | Thymic cancer | * | * | * | Malignant | 5*5*4 |
D1 | 28 | 18 | M | Bone | Osteosarcoma | * | T1N0M0 | IA | Malignant | * |
D2 | 29 | 57 | M | Bone | Osteosarcoma | * | T1N0M0 | IA | Malignant | * |
D3 | 30 | 28 | M | Bone | Osteosarcoma | * | T3N0M0 | IIIA | Malignant | 6.0 |
D4 | 31 | 68 | M | Lung | Squamous cell carcinoma with necrosis | 3 | T2bN0M0 | IIA | Malignant | * |
D5 | 32 | 68 | F | Lung | Adenocarcinoma with necrosis | 2 | T3N1M0 | IIIA | Malignant | * |
D6 | 33 | 42 | F | Lung | Small cell carcinoma | * | T4N1M0 | IIIA | Malignant | 3*2.5*3.5 |
D7 | 34 | 42 | M | Heart | Myxoma | * | * | * | Malignant | 5*3*0.8 |
D8 | 35 | 43 | F | Heart | Myxoma | * | * | * | Malignant | 2.5*2*0.5 |
D9 | 36 | 71 | F | Heart | Myxoma | * | * | * | Malignant | 4*3.5*1.5 |
E1 | 37 | 52 | M | Esophagus | Squamous cell carcinoma | 1 | T1N0M0 | I | Malignant | 4.5*2*1 |
E2 | 38 | 58 | F | Esophagus | Squamous cell carcinoma | 1 | T2N0M0 | II | Malignant | * |
E3 | 39 | 62 | M | Esophagus | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | * |
E4 | 40 | 37 | F | Stomach | Adenocarcinoma | 2 | T3N3M0 | IIIB | Malignant | * |
E5 | 41 | 38 | F | Stomach | Adenocarcinoma | 2--3 | T3N2M0 | IIIA | Malignant | * |
E6 | 42 | 31 | F | Stomach | Adenocarcinoma | 3 | T3N3M0 | IIIB | Malignant | * |
E7 | 43 | 56 | F | Small intestine | Adenocarcinoma | * | T3N2M0 | IIIB | Malignant | 8.0 |
E8 | 44 | 38 | M | Small intestine | Gastrointestinal stromal tumor (GIST) | * | * | * | Malignant | 10*7*5 |
E9 | 45 | 54 | F | Small intestine | Neuroendocrine carcinoma | * | T3N2M0 | IIIB | Malignant | 7.0 |
F1 | 46 | 58 | M | Colon | Adenocarcinoma | 2 | T3N0M0 | IIA | Malignant | * |
F2 | 47 | 52 | M | Colon | Adenocarcinoma | 2 | T3N2aM0 | IIIB | Malignant | 3*2*0.5 |
F3 | 48 | 46 | M | Colon | Neuroendocrine carcinoma | * | T3N1M0 | IIIB | Malignant | 7.0 |
F4 | 49 | 58 | M | Liver | Hepatocellular carcinoma | 2 | T2N0M0 | II | Malignant | * |
F5 | 50 | 48 | M | Liver | Hepatocellular carcinoma | 2 | T3N0M0 | IIIA | Malignant | * |
F6 | 51 | 62 | M | Liver | Cholangiocarcinoma with necrosis | 3 | T2aN0M0 | II | Malignant | * |
F7 | 52 | 53 | M | Oral cavity | Squamous cell carcinoma | 1 | T3N0M0 | III | Malignant | * |
F8 | 53 | 50 | F | Oral cavity | Squamous cell carcinoma | 1 | T3N0M0 | III | Malignant | * |
F9 | 54 | 41 | M | Oral cavity | Adenocarcinoma | 3 | T2N0M0 | II | Malignant | 9*4*4 |
G1 | 55 | 61 | F | Kidney | Clear cell carcinoma | 1 | T1N0M0 | I | Malignant | * |
G2 | 56 | 30 | M | Kidney | Papillary renal cell carcinoma | * | T1bN0M0 | I | Malignant | 5*4*4 |
G3 | 57 | 58 | M | Kidney | Chromophobe renal cell carcinoma | * | T1bN0M0 | I | Malignant | * |
G4 | 58 | 69 | M | Prostate | Adenocarcinoma (Gleason grade:2, Gleason score:2+1) | * | T3N0M0 | III | Malignant | * |
G5 | 59 | 73 | M | Prostate | Adenocarcinoma (Gleason grade:4, Gleason score:4+4) | * | T2N0M0 | II | Malignant | 4*3.5*3 |
G6 | 60 | 34 | M | Prostate | Adenocarcinoma (Gleason grade:5, Gleason score:5+5) | * | T2bN0M0 | II | Malignant | 3*2 |
G7 | 61 | 72 | M | Bladder | Low grade urothelial carcinoma | * | T1N0M0 | I | Malignant | * |
G8 | 62 | 65 | F | Bladder | High grade urothelial carcinoma | * | T3aN0M0 | IIIA | Malignant | * |
G9 | 63 | 51 | M | Bladder | Squamous cell carcinoma | 3 | T4aN1M0 | IIIA | Malignant | * |
H1 | 64 | 63 | F | Uterus | Clear cell carcinoma | * | T3bN1M0 | IIIC | Malignant | 6*5*3 |
H2 | 65 | 53 | F | Uterus | Endometrioid carcinoma | 1 | T1aN0M0 | IA | Malignant | 5.0*4.5*1.0 |
H3 | 66 | 48 | F | Uterus | Leiomyosarcoma | * | T2N1M0 | IIIC | Malignant | 9*9*7 |
H4 | 67 | 41 | F | Cervix | Adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 5*4*3 |
H5 | 68 | 76 | F | Cervix | Squamous cell carcinoma | 2 | T2N0M0 | II | Malignant | 4*3*2.5 |
H6 | 69 | 71 | F | Cervix | Squamous cell carcinoma | 2 | T1b1N0M0 | IB1 | Malignant | * |
H7 | 70 | 17 | M | Lymph node | Hodgkin's Lymphoma of left neck | * | * | * | Malignant | * |
H8 | 71 | 30 | M | Lymph node | T cell lymphoma of right armpit | * | * | * | Malignant | * |
H9 | 72 | 50 | F | Lymph node | Burkitt lymphoma of pelvic cavity | * | * | * | Malignant | 9*7*6 |
I1 | 73 | 32 | M | Skin | Squamous cell carcinoma of right thigh | 1 | T2N0M0 | II | Malignant | * |
I2 | 74 | 55 | M | Skin | Basal cell carcinoma of head | * | T2N0M0 | II | Malignant | * |
I3 | 75 | 66 | F | Skin | Malignant melanoma of chest wall | * | T4aN0M0 | IIB | Malignant | * |
I4 | 76 | 70 | F | Mesothelium | Malignant mesothelioma of right pleura | * | T2N0M0 | II | Malignant | 25*25*10 |
I5 | 77 | 29 | M | Mesothelium | Malignant mesothelioma of pleura | * | T1N0M0 | II | Malignant | 10*8*3 |
I6 | 78 | 52 | F | Mesothelium | Malignant mesothelioma of right pleura | * | T3N1M0 | IIIA | Malignant | 10*9*8 |
I7 | 79 | 22 | F | Nerve | Malignant schwannoma of left clavicle | * | * | * | Malignant | 4.5*4*2 |
I8 | 80 | 43 | F | Nerve | Malignant schwannoma of left thigh | * | * | * | Malignant | 4*3*2 |
I9 | 81 | 51 | F | Nerve | Malignant schwannoma of right elbow | * | * | * | Malignant | 3*2.5*2 |
Tissue Marker |